Group structure
8 companies in 3 countries
Loading…
8 companies in 3 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 84
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALEMBIC-BOSENTAN62.5 mg · Tablet | Bosentan | Canada | Authorised | |
| ALEMBIC-BOSENTAN125 mg · Tablet | Bosentan | Canada | Authorised | |
| ALEMBIC-DEFERASIROX (TYPE J)360 mg · Tablet | Deferasirox | Canada | Authorised | |
| ALEMBIC-LACOSAMIDE150 mg · Tablet | Lacosamide | Canada | Authorised | |
| ALEMBIC-LACOSAMIDE50 mg · Tablet | Lacosamide | Canada | Authorised | |
| ALEMBIC-LACOSAMIDE200 mg · Tablet | Lacosamide | Canada | Authorised | |
| ALEMBIC-LACOSAMIDE100 mg · Tablet | Lacosamide | Canada | Authorised | |
| ALEMBIC-TELMISARTAN80 mg · Tablet | Telmisartan | Canada | Authorised | |
| ALEMBIC-TELMISARTAN40 mg · Tablet | Telmisartan | Canada | Authorised | |
| ALEMBIC-TELMISARTAN/HCTZ25 mg + 80 mg · Tablet | Hydrochlorothiazide, Telmisartan | Canada | Authorised | |
| ALEMBIC-TELMISARTAN/HCTZ12.5 mg + 80 mg · Tablet | Hydrochlorothiazide, Telmisartan | Canada | Authorised | |
| AMANTADINE HYDROCHLORIDE100mg · Capsule | Amantadine | United States | Marketed | 1987 |
| ARIPIPRAZOLE10mg | 15mg | 20mg | 30mg · Tablet, orally disintegrating | Aripiprazole | United States | Marketed | 2012 |
| BETAMETHASONE VALERATE0.12% · Aerosol, foam | Betamethasone | United States | Marketed | 2012 |
| BIMATOPROST0.03% · Solution/drops | Bimatoprost | United States | Marketed | 2014 |
| BOSUTINIB MONOHYDRATE100mg base | 500mg base · Tablet | Bosutinib | United States | Marketed | 2025 |
| CANDESARTAN CILEXETIL4 mg · Tablet | Candesartan cilexetil | Canada | Authorised | |
| CANDESARTAN CILEXETIL32 mg · Tablet | Candesartan cilexetil | Canada | Authorised | |
| CANDESARTAN CILEXETIL16 mg · Tablet | Candesartan cilexetil | Canada | Authorised | |
| CANDESARTAN CILEXETIL8 mg · Tablet | Candesartan cilexetil | Canada | Authorised | |
| CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS16 mg + 12.5 mg · Tablet | Candesartan cilexetil, Hydrochlorothiazide | Canada | Authorised | |
| CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS32 mg + 12.5 mg · Tablet | Candesartan cilexetil, Hydrochlorothiazide | Canada | Authorised | |
| CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS32 mg + 25 mg · Tablet | Candesartan cilexetil, Hydrochlorothiazide | Canada | Authorised | |
| CELECOXIB200 mg · Capsule | Celecoxib | Canada | Authorised | |
| CELECOXIB100 mg · Capsule | Celecoxib | Canada | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 31 | 31 | 0 | CompaniesAll medicines |
| United States | 23 | 20 | 3 | CompaniesAll medicines |
| Spain | 22 | 8 | 14 | CompaniesAll medicines |
| Netherlands | 8 | 8 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Colombia, Malaysia, Singapore, Sweden
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Keep Alembic’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.